Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy
Robert H. Press(Baptist Hospital of Miami), Kristin Higgins(Emory University), Richard J. Cassidy(Florida Cancer Specialists & Research Institute), Gabriel Sica(Emory University), Pretesh Patel(Emory University), Walter J. Curran(Piedmont Cancer Institute), Hui‐Kuo G. Shu(Emory University), Chao Zhang(Hubei University of Medicine), Matthew J. Ferris(University of Maryland, Baltimore), Conor Steuer(Emory University), Suresh S. Ramalingam(Emory University), Jim Zhong(Emory University), Rathi N. Pillai(Emory University), Shannon Kahn(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 9
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k